Your session is about to expire
← Back to Search
Oral Testosterone Undecanoate for Low Libido
Study Summary
This trial will test Kyzatrax®'s safety and effectiveness at increasing testosterone levels over 3 months. Subjects will take a capsule daily and have multiple blood tests.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2016 Phase 3 trial • 222 Patients • NCT02722278Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does this research initiative include elderly participants?
"The upper age limit for this trial is 75 years old, while the lower threshold of enrolment is 21."
What are the eligibility criteria for participation in this experiment?
"This study is seeking 30 individuals with low libido, aged 21 to 75. To be eligible for the trial, these requirements must be met."
Is Active a safe and viable treatment option for patients?
"Since this is a phase 2 trial, meaning there are some safety data but no efficacy data available yet, our team at Power has assigned an assessment score of 2 to Active's safety."
Is there still capacity for individuals to join this examination?
"As the details on clinicaltrials.gov indicate, this particular trial is not currently searching for participants anymore; it first appeared online on December 1st 2023 and was last updated October 8th 2023. However, there are still 8 other trials that presently require additional research subjects."
Share this study with friends
Copy Link
Messenger